Skip to main content

Advertisement

SpringerLink
Log in

The Retrovirus-mediated Antisense Human Telomerase RNA (hTR) Gene Limits the Growth of Hepatocellular Carcinoma Growth in Cell Culture and Animals

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aim To investigate the inhibitory effect of retrovirus-mediated antisense human telomerase RNA (hTR) gene therapy on hepatocelluar carcinoma. Methods We first constructed the sense and antisense hTR vectors and then transfected these into HepG2 cells. Telomerase activity, cell growth curves, proliferating cell nuclear antigen expression (PCNA), cell cycle distribution, and cell apoptosis were detected by the means of telemere repeat amplification protocol (TRAP), MTT assay, immunofluorescence, flow cytometric analysis, and transferase-mediated nick end labeling (TUNEL), respectively. In order to further confirm the therapeutic effect of this gene therapy, we developed an experimental line of HepG2 tumor-bearing nude mice by and directly injected these with retrovirus expressing the antisense hTR gene. Tumor growth was determined by tumor volume, and cell apoptosis was analyzed by TUNEL. Results The antisense hTR gene was shown to be successfully integrated into the target cells’ genome. HepG2 cells transfected with the antisense hTR gene showed down-regulated telomerase activity, inhibited cell growth, decreased PCNA expression, and increased apoptotic rate. Moreover, flow cytometry revealed a decrease of cells in the S phase with cell cycle arrest at the G2/M phase. In the antisense hTR-treated group, tumor growth was significantly reduced and showed an increase of apoptotic cells. Conclusion The results indicate that the specific inhibitor of the hTR template is likely to be a very efficient tool for hepatocellular carcinoma research and may possess potential therapeutic significance in the future clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Murray CJ, Lopez AD (1996) Evidence-based health policy––lessons from the Global Burden of Disease Study. Science 274:740–743 [PMID: 8966556]

    Article  PubMed  CAS  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156 [PMID: 11668491]

    Article  PubMed  CAS  Google Scholar 

  3. Sutton FM, Russell NC, Guinee VF, Alpert E (1988) Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol 6:321–328 [PMID: 2448427]

    PubMed  CAS  Google Scholar 

  4. Cunningham AP, Love WK, Zhang RW et al (2006) Telomerase inhibition in cancer therapeutics: molecular-based approaches. Curr Med Chem 13:2875–2888 [PMID: 17073634]

    Article  PubMed  CAS  Google Scholar 

  5. Pendino F, Tarkanyi I, Dudognon C et al (2006) Telomeres and telomerase: pharmacological targets for new anticancer strategies? Curr Cancer Drug Targets 6:147–180 [PMID: 16529544]

    Article  PubMed  CAS  Google Scholar 

  6. Feng J, Funk WD, Wang SS et al (1995) The RNA component of human telomerase. Science 269:1236–1241 [PMID: 7544491]

    Article  PubMed  CAS  Google Scholar 

  7. Sato R, Maesawa C, Fujisawa K et al (2004) Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut 53:1001–1009 [PMID: 15194652]

    Article  PubMed  CAS  Google Scholar 

  8. Kim NW, Piatyszek MA, Prowse KR et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015 [PMID: 7605428]

    Article  PubMed  CAS  Google Scholar 

  9. Kondo Y, Koga S, Komata T et al (2000) Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. Oncogene 19:2205–2211 [PMID: 10822370]

    Article  PubMed  CAS  Google Scholar 

  10. Harley CB, Villeponteau B (1995) Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5:249–255 [PMID: 7613096]

    Article  PubMed  CAS  Google Scholar 

  11. Kim NW, Piatyszek MA, Prowse KR et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015 [PMID: 7605428]

    Article  PubMed  CAS  Google Scholar 

  12. Hahn WC, Counter CM, Lundberg AS et al (1999) Creation of human tumor cells with defined genetic elements. Nature 400:464–468 [PMID: 10440377]

    Article  PubMed  CAS  Google Scholar 

  13. Hahn WC, Stewart SA, Brooks MW et al (1999) Inhibition of telomerase limits the growth of human cancer cells. Nature Med 5:1164–1170 [PMID: 10502820]

    Article  PubMed  CAS  Google Scholar 

  14. Kondo Y, Koga S, Komata T et al (2000) Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. Oncogene 19:2205–2211 [PMID: 10822370]

    Article  PubMed  CAS  Google Scholar 

  15. Fu XH, Zhang JS, Zhang N et al (2005) Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. World J Gastroenterol 11:785–790 [PMID: 15682468]

    PubMed  CAS  Google Scholar 

  16. Song JS, Kim HP, Yoon WS et al (2003) Adenovirus-mediated suicide gene therapy using the human telomerase catalytic gene promoter induced apoptosis of ovarian cancer cell line. Biosci Biotechnol Biochem 67:2344–2350 [PMID: 14646192]

    Article  PubMed  CAS  Google Scholar 

  17. Zhang P, Xu Q, Chen WT et al (2005) Synergistic down-regulation of telomerase by all-trans retinoic acid and Antisense oligonucleotide in oral squamous cell carcinoma cell line(Tca8113). Oral Oncol 41:909–915 [PMID: 16051514]

    Article  PubMed  CAS  Google Scholar 

  18. de Souza Nascimento P, Alves G, Fiedler W (2006) Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol Rep 16:423–428 [PMID: 16820926]

    PubMed  Google Scholar 

  19. Ghosh U, Bhattacharyya NP (2005) Benzamide and 4-amino 1,8 naphthalimide treatment inhibit telomerase activity by down-regulating the expression of telomerase associated and inhibiting the poly(ADP-ribosyl)ation of telomerase reverse transcriptase in cultured cells. FEBS J 272:4237–4248 [16098204]

    Article  PubMed  CAS  Google Scholar 

  20. Crystal RG (1995) Transfer of genes to humans: early lessons and obstacles to success. Science 270:404–410 [PMID: 7569994]

    Article  PubMed  CAS  Google Scholar 

  21. Kotani H, Newton PB, Zhang S et al (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5:19–28 [PMID: 8155767]

    Article  PubMed  CAS  Google Scholar 

  22. Bisoffi M, Chakerian AE, Fore ML et al (1998) Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA. Eur J Cancer 34:1242–1249 [PMID: 9849487]

    Article  PubMed  CAS  Google Scholar 

  23. Zhu X, Kumar R, Mandal M et al (1996) Cell cycle-dependent modulation of telomerase activity in tumor cells. Natl Acad Sci 93:6091–6095 [PMID: 8650224]

    Article  CAS  Google Scholar 

  24. Zhang RG, Zhang RP, Wang XW et al (2002) Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Cell Res 12:55–62 [PMID: 11942411]

    Article  PubMed  Google Scholar 

  25. Zhang F, Jia Z, Wei Y et al (2002) In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside. Planta Med 68:115–118 [PMID: 11859459]

    Article  PubMed  CAS  Google Scholar 

  26. Satra M, Tsouqos I, Papanikolaou V, et al (2006) Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells. Int J Radiat Biol 82:401–409 [PMID: 16846975]

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Shandong Provincial Hospital, Shandong University, Jing 5 Wei 7 Road, no. 324, Ji’nan, Shandong Province, 250021, China

    Ji-yong Liu, Qiang Zhu, Jianfeng Li, Shulei Zhao & Luning Li

Authors
  1. Ji-yong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianfeng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shulei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luning Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ji-yong Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Jy., Zhu, Q., Li, J. et al. The Retrovirus-mediated Antisense Human Telomerase RNA (hTR) Gene Limits the Growth of Hepatocellular Carcinoma Growth in Cell Culture and Animals. Dig Dis Sci 53, 1122–1130 (2008). https://doi.org/10.1007/s10620-007-9980-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-9980-4

Keywords

Search

Navigation